Ph II Study of Perifosine Plus Gleevec for Patients With GIST
Status:
Completed
Trial end date:
2011-10-01
Target enrollment:
Participant gender:
Summary
This is a Phase II trial designed to determine the efficacy and safety of perifosine plus
imatinib mesylate in patients with advanced GIST who develop progressive disease or
recurrence while receiving imatinib mesylate.